Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

PHASE3TerminatedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

March 24, 2025

Study Completion Date

March 24, 2025

Conditions
Asthma
Interventions
BIOLOGICAL

Tezepelumab

Tezepelumab subcutaneous injection

OTHER

Placebo

Placebo subcutaneous injection

Trial Locations (64)

10330

Research Site, Bangkok

10459

Research Site, The Bronx

11000

Research Site, Bang Kra So

15046

Research Site, Lima

16059

Research Site, Bursa

16499

Research Site, Suwon

19713

Research Site, Newark

23100

Research Site, Bychawa

33014

Research Site, Miami Lakes

33016

Research Site, Hialeah

34899

Research Site, Istanbul

35040

Research Site, Izmir

44100

Research Site, Guadalajara

44130

Research Site, Guadalajara

44200

Research Site, Guadalajara

64460

Research Site, Monterrey

67201

Research Site, Moravský Krumlov

68510

Research Site, Lincoln

77339

Research Site, Kingwood

78250

Research Site, San Luis Potosí City

79902

Research Site, El Paso

80206

Research Site, Denver

90110

Research Site, Hat Yai

91910

Research Site, Veracruz

92663

Research Site, Newport Beach

208002

Research Site, Kanpur

305001

Research Site, Ajmer

390022

Research Site, Vadodara

3341643

Research Site, Curicó

7500010

Research Site, Santiago

7500588

Research Site, Santiago

7500691

Research Site, Santiago

7500692

Research Site, Santiago

7500698

Research Site, Santiago

7750495

Research Site, Santiago

8241479

Research Site, Santiago

90035074

Research Site, Porto Alegre

18618-686

Research Site, Botucatu

80730-150

Research Site, Curitiba

91350-200

Research Site, Porto Alegre

40060-330

Research Site, Salvador

09715090

Research Site, São Bernardo do Campo

01223-001

Research Site, São Paulo

18040-425

Research Site, Sorocaba

L1S 2J5

Research Site, Ajax

G1V4G5

Research Site, Québec

625 00

Research Site, Brno

500 05

Research Site, Hradec Králové

377 01

Research Site, Jindřichův Hradec

779 00

Research Site, Olomouc

700 30

Research Site, Ostrava

0 3100

Research Site, Mexico City

15-704

Research Site, Bialystok

85-231

Research Site, Bydgoszcz

26-060

Research Site, Chęciny

86-300

Research Site, Grudziądz

27-400

Research Site, Ostrowiec Świętokrzyski

61-578

Research Site, Poznan

35-205

Research Site, Rzeszów

41-208

Research Site, Sosnowiec

05505

Research Site, Seoul

07061

Research Site, Seoul

143-729

Research Site, Seoul

06620

Research Site, Ankara

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

AstraZeneca

INDUSTRY